Latest News & Features
Americas
Isomorphic Labs' head of IP shares why the first wave of AI-driven drug development stumbled, how data became pharma's most valuable currency, and why inventorship questions could make or break billion-dollar deals in machine learning. 21 October 2025
Americas
LSIPR is gearing up for the 5th annual LSPN North America Fall Conference, starting October 21, in San Francisco, California. 21 October 2025
Americas
The Japanese pharmaceutical company has filed a cluster of lawsuits against generic drug makers asserting its patent protection and market exclusivity over the high-selling ALS treatment. 20 October 2025
Americas
A US Senate subcommittee hearing on patent eligibility reform has David Kappos, former USPTO director, believing that “there’s a better chance than ever” of a pending bill becoming law, finds Sarah Speight. 17 October 2025
Europe
The court rejected Novartis’s request for emergency measures against a Spanish importer after the pharma company failed to meet the test to enforce an injunction, the winning lawyers told LSIPR. 16 October 2025
Big Pharma
After saving hundreds of thousands of dollars ‘with my laptop and ChatGPT’, the biotech’s trademarks leader says lawyers need to discover how the tech can reduce external spend. 16 October 2025
Americas
In-house IP director at RefleXion talks about protecting complex medtech, why startups can't afford to cut corners on early decisions, and when to employ outside expertise. 15 October 2025
Careers
The new addition by Latham & Watkins is a “distinguished practitioner” and marks another departure from Simmons & Simmons. 15 October 2025
Europe
Artificial intelligence requires vast amounts of data, but its true value now lies in accuracy and careful curation, finds Sarah Speight. 15 October 2025
Careers
Hoffmann Eitle has boosted its already impressive UPC team with the addition of a tech expert and new co-chair of the firm’s patent litigation group. 14 October 2025